Inotek Pharmaceuticals to Present at the 2016 Ophthalmology Innovation Summit
LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) today announced that David P. Southwell, President and Chief Executive Officer of Inotek, will present at the 2016 Ophthalmology Innovation Summit.
